Immunoassay & SerologyChemiluminescence ImmunoassayAvailability varies by country

Elecsys® Anti-SARS-CoV-2 S

By Roche Diagnostics · Switzerland

Product TypeAssay Kit
TechnologyChemiluminescence Immunoassay
Regulatory StatusAvailability varies by country
Sample TypesSerum, Plasma
Catalog / REF09 289 267 190
Elecsys® Anti-SARS-CoV-2 S — Roche Diagnostics product image

Key takeaways

Elecsys® Anti-SARS-CoV-2 S is a product in the Immunoassay & Serology category, manufactured by Roche Diagnostics (Switzerland). Listed regulatory status: Availability varies by country (as reported by the manufacturer).

  • Platform: Chemiluminescence Immunoassay
  • Sample types: serum, plasma
  • Applications: Respiratory, Emerging Pathogens

Summary

Elecsys® Anti-SARS-CoV-2 S is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.

Classification

Category
Immunoassay & Serology
Subcategory
Infectious Disease Serology
Product Type
Assay Kit
Technology
Chemiluminescence Immunoassay

Application

Application Area
Respiratory, Emerging Pathogens

Workflow

Sample Types
Serum, Plasma

Regulatory Status

Availability varies by country

Reported from manufacturer sources and not independently verified.

Buyer Notes

Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.

Related Test Guides

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

  • qualitative detection of antibodies in human serum and plasma. The electrochemiluminescence immunoassay ECLIA is intended for use on cobas e immunoassay analyzers.
    Roche DiagnosticsCategory L1,Category L2,Technology PlatformManufacturer Page2026-10-10

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-04

Updated

2026-10-10

Disclaimer

availability varies

Explore more